UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?

Surgery, 2016-01, Vol.159 (1), p.320-335

2016

Volltextzugriff (PDF)

Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas

Histopathology, 2017-10, Vol.71 (4), p.503-510

2017

Volltextzugriff (PDF)

Limitations of somatostatin scintigraphy in primary small bowel neuroendocrine tumors

The Journal of surgical research, 2014-08, Vol.190 (2), p.548-553

2014

Volltextzugriff (PDF)

Presacral neuroendocrine tumors associated with the Currarino syndrome

American journal of medical genetics. Part A, 2021-05, Vol.185 (5), p.1582-1588

2021

Volltextzugriff (PDF)

RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner

Cancer research (Chicago, Ill.), 2014-11, Vol.74 (22), p.6661-6670

2014

Volltextzugriff (PDF)

Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?

Annals of surgical oncology, 2022-10, Vol.29 (11), p.6936-6946

2022

Volltextzugriff (PDF)

Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs)

Surgery, 2019-01, Vol.165 (1), p.166-175

2019

Volltextzugriff (PDF)

Increased Grade in Neuroendocrine Tumor Metastases Negatively Impacts Survival

Annals of surgical oncology, 2017-08, Vol.24 (8), p.2206-2212

2017

Volltextzugriff (PDF)

The Distal Predilection of Small Bowel Neuroendocrine Tumors

Annals of surgical oncology, 2018-10, Vol.25 (11), p.3207-3213

2018

Volltextzugriff (PDF)

Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors

Surgery, 2017-01, Vol.161 (1), p.272-279

2017

Volltextzugriff (PDF)

Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors

Clinical cancer research, 2020-04, Vol.26 (8), p.2011-2021

2020

Volltextzugriff (PDF)

Evolution of Neuroendocrine Tumor Therapy

Surgical oncology clinics of North America, 2020-04, Vol.29 (2), p.145-163

2020

Volltextzugriff (PDF)

The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors

Annals of surgical oncology, 2019-08, Vol.26 (8), p.2525-2532

2019

Volltextzugriff (PDF)

Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors

Pancreas, 2017-02, Vol.46 (2), p.151-156

2017

Volltextzugriff (PDF)

A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs)

Pancreas, 2013-04, Vol.42 (3), p.405-410

2013

Volltextzugriff (PDF)

Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution

Pancreas, 2014-03, Vol.43 (2), p.219-225

2014

Volltextzugriff (PDF)

Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate in Patients With Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years' Assessment

Clinical nuclear medicine, 2017-06, Vol.42 (6), p.436-443

2017

Volltextzugriff (PDF)

Is Multifocality an Indicator of Aggressive Behavior in Small Bowel Neuroendocrine Tumors?

Pancreas, 2017-10, Vol.46 (9), p.1115-1120

2017

Volltextzugriff (PDF)

Overexpression of Membrane Proteins in Primary and Metastatic Gastrointestinal Neuroendocrine Tumors

Annals of surgical oncology, 2013-12, Vol.20 (Suppl 3), p.739-746

2013

Volltextzugriff (PDF)

Circulating Biomarkers in Neuroendocrine Tumors of the Enteropancreatic Tract: Application to Diagnosis, Monitoring Disease, and as Prognostic Indicators

Endocrinology and metabolism clinics of North America, 2010-12, Vol.39 (4), p.777-790

2010

Volltextzugriff (PDF)

Comparison of Clinicopathologic Factors in 122 Patients with Resected Pancreatic and Ileal Neuroendocrine Tumors from a Single Institution

Annals of surgical oncology, 2012-03, Vol.19 (3), p.966-972

2012

Volltextzugriff (PDF)

Localization of Unknown Primary Site with 68 Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor

Journal of Nuclear Medicine, 2017-07, Vol.58 (7), p.1054-1057

2017

Volltextzugriff (PDF)

Potential for Increasing Uptake of Radiolabeled 68 Ga-DOTATOC and 123 I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat

Cancer biotherapy & radiopharmaceuticals, 2021-10, Vol.36 (8), p.632-641

2021

Volltextzugriff (PDF)

Everolimus Plus Octreotide Long‐Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT‐2 Study

The oncologist (Dayton, Ohio), 2013-01, Vol.18 (1), p.46-53

2013

Volltextzugriff (PDF)

Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors

Regulatory peptides, 2001-01, Vol.96 (3), p.113-117

2001

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Chemistry

SpracheEnglisch

ThemaNeuroendocrine Tumors - Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(26)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?

Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas

Limitations of somatostatin scintigraphy in primary small bowel neuroendocrine tumors

Presacral neuroendocrine tumors associated with the Currarino syndrome

RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner

Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?

Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs)

Increased Grade in Neuroendocrine Tumor Metastases Negatively Impacts Survival

The Distal Predilection of Small Bowel Neuroendocrine Tumors

Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors

Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors

Evolution of Neuroendocrine Tumor Therapy

The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors

Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors

A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs)

Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution

Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate in Patients With Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years' Assessment

Is Multifocality an Indicator of Aggressive Behavior in Small Bowel Neuroendocrine Tumors?

Overexpression of Membrane Proteins in Primary and Metastatic Gastrointestinal Neuroendocrine Tumors

Circulating Biomarkers in Neuroendocrine Tumors of the Enteropancreatic Tract: Application to Diagnosis, Monitoring Disease, and as Prognostic Indicators

Comparison of Clinicopathologic Factors in 122 Patients with Resected Pancreatic and Ileal Neuroendocrine Tumors from a Single Institution

Localization of Unknown Primary Site with 68 Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor

Potential for Increasing Uptake of Radiolabeled 68 Ga-DOTATOC and 123 I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat

Everolimus Plus Octreotide Long‐Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT‐2 Study

Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors

Aktive Filter

Suchergebnisse filtern